These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

380 related items for PubMed ID: 29728879

  • 1. Postoperative Adjuvant Trans-Arterial Chemoembolization for Patients with Hepatocellular Carcinoma and Portal Vein Tumor Thrombus.
    Liu S, Guo L, Li H, Zhang B, Sun J, Zhou C, Zhou J, Fan J, Ye Q.
    Ann Surg Oncol; 2018 Jul; 25(7):2098-2104. PubMed ID: 29728879
    [Abstract] [Full Text] [Related]

  • 2. Survival outcomes of hepatic resection compared with transarterial chemoembolization or sorafenib for hepatocellular carcinoma with portal vein tumor thrombosis.
    Lee JM, Jang BK, Lee YJ, Choi WY, Choi SM, Chung WJ, Hwang JS, Kang KJ, Kim YH, Chauhan AK, Park SY, Tak WY, Kweon YO, Kim BS, Lee CH.
    Clin Mol Hepatol; 2016 Mar; 22(1):160-7. PubMed ID: 27044767
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of transcatheter arterial chemoembolization combined with either 125I seed implantation or apatinib in hepatocellular carcinoma with portal vein tumor thrombosis: A retrospective comparative study.
    Li Y, Li H, Hu H, Yuan H, Zhao Y.
    J Cancer Res Ther; 2020 Mar; 16(7):1691-1697. PubMed ID: 33565518
    [Abstract] [Full Text] [Related]

  • 7. Appropriate treatment strategies improve survival of hepatocellular carcinoma patients with portal vein tumor thrombus.
    Ye JZ, Zhang YQ, Ye HH, Bai T, Ma L, Xiang BD, Li LQ.
    World J Gastroenterol; 2014 Dec 07; 20(45):17141-7. PubMed ID: 25493028
    [Abstract] [Full Text] [Related]

  • 8. Transarterial chemoembolization plus immune checkpoint inhibitor as postoperative adjuvant therapy for hepatocellular carcinoma with portal vein tumor thrombus: A multicenter cohort study.
    Yuan L, Feng J, Zhang Y, Lu C, Xu L, Liang C, Liu Z, Mao F, Xiang Y, Wang W, Wang K, Cheng S.
    Eur J Surg Oncol; 2023 Jul 07; 49(7):1226-1233. PubMed ID: 36739252
    [Abstract] [Full Text] [Related]

  • 9. Comprehensive treatments for hepatocellular carcinoma with tumor thrombus in major portal vein.
    Ye HH, Ye JZ, Xie ZB, Peng YC, Chen J, Ma L, Bai T, Chen JZ, Lu Z, Qin HG, Xiang BD, Li LQ.
    World J Gastroenterol; 2016 Apr 07; 22(13):3632-43. PubMed ID: 27053855
    [Abstract] [Full Text] [Related]

  • 10. Prognostic factors for survival after transarterial chemoembolization combined with microwave ablation for hepatocellular carcinoma.
    Ni JY, Sun HL, Chen YT, Luo JH, Chen D, Jiang XY, Xu LF.
    World J Gastroenterol; 2014 Dec 14; 20(46):17483-90. PubMed ID: 25516662
    [Abstract] [Full Text] [Related]

  • 11. Combination Therapy of Chemoembolization and Hepatic Arterial Infusion Chemotherapy in Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis Compared with Chemoembolization Alone: A Propensity Score-Matched Analysis.
    Liu BJ, Gao S, Zhu X, Guo JH, Kou FX, Liu SX, Zhang X, Wang XD, Cao G, Chen H, Liu P, Zhu LZ, Xu HF, Yang RJ.
    Biomed Res Int; 2021 Dec 14; 2021():6670367. PubMed ID: 34337041
    [Abstract] [Full Text] [Related]

  • 12. Therapeutic value of transcatheter arterial chemoembolization combined with portal vein embolization for primary hepatocellular carcinoma with portal vein tumor thrombus: a pilot study.
    Tan X, Xie P, Liu J, Wu H, Xie Y.
    Asia Pac J Clin Oncol; 2015 Sep 14; 11(3):e6-e12. PubMed ID: 25228074
    [Abstract] [Full Text] [Related]

  • 13. Hepatic resection versus transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with portal vein tumor thrombus.
    Peng ZW, Guo RP, Zhang YJ, Lin XJ, Chen MS, Lau WY.
    Cancer; 2012 Oct 01; 118(19):4725-36. PubMed ID: 22359112
    [Abstract] [Full Text] [Related]

  • 14. Transarterial chemoembolization versus best supportive care for patients with hepatocellular carcinoma with portal vein tumor thrombus：a multicenter study.
    Xiang X, Lau WY, Wu ZY, Zhao C, Ma YL, Xiang BD, Zhu JY, Zhong JH, Li LQ.
    Eur J Surg Oncol; 2019 Aug 01; 45(8):1460-1467. PubMed ID: 31005471
    [Abstract] [Full Text] [Related]

  • 15. Microwave ablation of hepatocellular carcinoma with portal vein tumor thrombosis after transarterial chemoembolization: a prospective study.
    Long J, Zheng JS, Sun B, Lu N.
    Hepatol Int; 2016 Jan 01; 10(1):175-84. PubMed ID: 26742761
    [Abstract] [Full Text] [Related]

  • 16. Apatinib Combined With Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma and Portal Vein Tumor Thrombus: A Multicenter Retrospective Study.
    Fan W, Yuan G, Fan H, Li F, Wu Y, Zhao Y, Yao W, Wang Y, Xue M, Yang J, Li J.
    Clin Ther; 2019 Aug 01; 41(8):1463-1476. PubMed ID: 31303279
    [Abstract] [Full Text] [Related]

  • 17. Combined endovascular brachytherapy, sorafenib, and transarterial chemobolization therapy for hepatocellular carcinoma patients with portal vein tumor thrombus.
    Zhang ZH, Liu QX, Zhang W, Ma JQ, Wang JH, Luo JJ, Liu LX, Yan ZP.
    World J Gastroenterol; 2017 Nov 21; 23(43):7735-7745. PubMed ID: 29209114
    [Abstract] [Full Text] [Related]

  • 18. Anlotinib followed by transarterial chemoembolization and radiofrequency ablation is a safe and effective initial treatment for hepatocellular carcinoma patients with portal vein tumor thrombus: A retrospective case series study.
    Wang J, Li X, Wang F, Shi D, Zhang J.
    J Cancer Res Ther; 2021 Jul 21; 17(3):619-624. PubMed ID: 34269290
    [Abstract] [Full Text] [Related]

  • 19. Hepatocellular carcinoma with portal vein tumor thrombus: treatment with transarterial chemoembolization combined with sorafenib--a retrospective controlled study.
    Zhu K, Chen J, Lai L, Meng X, Zhou B, Huang W, Cai M, Shan H.
    Radiology; 2014 Jul 21; 272(1):284-93. PubMed ID: 24708192
    [Abstract] [Full Text] [Related]

  • 20. Transarterial Chemoembolization (TACE) Combined with Sorafenib in Treatment of HBV Background Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: A Propensity Score Matching Study.
    Yuan J, Yin X, Tang B, Ma H, Zhang L, Li L, Chen R, Xie X, Ren Z.
    Biomed Res Int; 2019 Jul 21; 2019():2141859. PubMed ID: 31467872
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.